Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (PROSE/ICAC-20)

William Busse & Samuel Arbes
A three-armed prospective randomized double-blind placebo-controlled trial investigating the efficacy of standard care plus 4-5 months of treatment with (a) a boost of inhaled corticosteroid therapy Flovent Diskus (fluticasone) versus (b) Xolair(omalizumab) or (c) placebo Xolair (omalizumab) and placebo Flovent Diskus (fluticasone) in reducing the exacerbations during the fall season.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.